The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
AstraZeneca
Arvinas Inc.
Seagen Inc.
Elicio Therapeutics
TransThera Sciences (Nanjing), Inc.
Elevation Oncology
TransThera Sciences (Nanjing), Inc.
MacroGenics
INSYS Therapeutics Inc
Auron Healthcare GmbH